An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2012
At a glance
- Drugs Bardoxolone methyl (Primary) ; Digoxin; Rosuvastatin
- Indications Arrhythmias; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemias; Hypertriglyceridaemia
- Focus Pharmacokinetics
- Sponsors Reata Pharmaceuticals
- 29 Jun 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 29 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 19 May 2012 New trial record